Dramatic Response of Brain Metastasis from EGFR-mutation-positive NSCLC to Dacomitinib

The central nervous system efficacy of dacomitinib, a key agent used in the treatment of epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC), is unclear. We herein present our experience in the use of dacomitinib for the treatment of multiple brain metastatic lesions fr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Intern Med
Autori principali: Kudo, Kenichiro, Kawakado, Keita, Kawajiri, Tomoka, Nishi, Tatsuya, Makimoto, Go, Tamura, Tomoki, Kuyama, Shoichi, Tanimoto, Mitsune
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Japanese Society of Internal Medicine 2020
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7434540/
https://ncbi.nlm.nih.gov/pubmed/32296006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.4449-20
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi